ALMSNasdaqPharmaceutical PreparationsFiscal year ends December 31
ALUMIS INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$6.34+0.22 (+3.59%)
Close on Oct 19, 2026
- Market cap
- $809.56M
- P/E (TTM)
- –
- Dividend yield
- –
ALUMIS INC. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | % of revenue | YoY |
|---|---|---|---|---|---|
| License | $17.39M | – | – | 72.3% | – |
| Collaboration | $6.66M | – | – | 27.7% | – |
By region
From the segment and revenue-disaggregation notes of Alumis's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.